Pregnancy-related venous thromboembolic events are important preventable causes of morbidity and mortality in South Africa. All
pregnant patients should be evaluated for thrombotic risk at different stages of their pregnancy and appropriate preventive steps taken.
Maternal and fetal wellbeing must be kept in mind, as well as physiological changes leading to altered drug pharmacokinetics. Managing
the patient with thrombotic risk in pregnancy, diagnosing venous thromboembolism (VTE) during pregnancy and treatment of venous
thromboembolic events should be managed by a team. Excellent recent reviews on this subject are available, including risk factor
stratification in anticoagulant therapy; managing the patient at time of labour; diagnosing VTE; and managing neuraxial anaesthesia in the
pregnant patient on anticoagulant therapy.